CN Patent

CN113573696A — 用于治疗过剂量和奖赏系障碍的组合物、装置和方法

Assigned to Aegis Therapeutics LLC · Expires 2021-10-29 · 5y expired

What this patent protects

提供了适于鼻部递送的药物产品，其包括填充有包含纳曲酮的药物组合物的装置。还提供了用该药物产品治疗酒精使用障碍和相关状况的制剂和方法。

USPTO Abstract

提供了适于鼻部递送的药物产品，其包括填充有包含纳曲酮的药物组合物的装置。还提供了用该药物产品治疗酒精使用障碍和相关状况的制剂和方法。

Drugs covered by this patent

nalmefene-hydrochloride (NALMEFENE HYDROCHLORIDE)

Patent Metadata

Patent number: CN113573696A
Jurisdiction: CN
Classification: —
Expires: 2021-10-29
Drug substance claim: No
Drug product claim: No
Assignee: Aegis Therapeutics LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.